11/18
11:38 am
eyen
Eyenovia Stock Tumbles on Termination of Phase III Myopia Study [Yahoo! Finance]
Low
Report
Eyenovia Stock Tumbles on Termination of Phase III Myopia Study [Yahoo! Finance]
11/18
11:36 am
eyen
Eyenovia, Inc. (NASDAQ: EYEN) had its "neutral" rating re-affirmed by analysts at LADENBURG THALM/SH SH.
Low
Report
Eyenovia, Inc. (NASDAQ: EYEN) had its "neutral" rating re-affirmed by analysts at LADENBURG THALM/SH SH.
11/18
08:07 am
eyen
Eyenovia, Inc. (NASDAQ: EYEN) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $12.00.
High
Report
Eyenovia, Inc. (NASDAQ: EYEN) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating. They now have a $2.00 price target on the stock, down previously from $12.00.
11/18
07:39 am
eyen
Eyenovia stock plummets following Phase III myopia trial failure [Yahoo! Finance]
High
Report
Eyenovia stock plummets following Phase III myopia trial failure [Yahoo! Finance]
11/15
02:08 pm
eyen
Eyenovia, Inc. (NASDAQ: EYEN) had its "hold" rating re-affirmed by analysts at Brookline Capital Management.
Low
Report
Eyenovia, Inc. (NASDAQ: EYEN) had its "hold" rating re-affirmed by analysts at Brookline Capital Management.
11/15
02:08 pm
eyen
Eyenovia, Inc. (NASDAQ: EYEN) had its "market perform" rating re-affirmed by analysts at William Blair.
Medium
Report
Eyenovia, Inc. (NASDAQ: EYEN) had its "market perform" rating re-affirmed by analysts at William Blair.
11/15
01:21 pm
eyen
Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline [Yahoo! Finance]
Medium
Report
Eyenovia Stock Sinks As Pivotal Trial Fails To Hit Primary Efficacy Goal, Analyst Downgrades Due To Limited Capital And Near Term Upside From Pipeline [Yahoo! Finance]
11/15
07:41 am
eyen
Eyenovia Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
High
Report
Eyenovia Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]
11/15
07:09 am
eyen
Eyenovia Provides Update on Phase 3 CHAPERONE Study [Yahoo! Finance]
High
Report
Eyenovia Provides Update on Phase 3 CHAPERONE Study [Yahoo! Finance]
11/15
07:00 am
eyen
Eyenovia Provides Update on Phase 3 CHAPERONE Study
High
Report
Eyenovia Provides Update on Phase 3 CHAPERONE Study
11/13
08:05 am
eyen
Eyenovia, Inc. (NASDAQ: EYEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
High
Report
Eyenovia, Inc. (NASDAQ: EYEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $12.00 price target on the stock.
11/13
02:26 am
eyen
Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
High
Report
Eyenovia Inc (EYEN) Q3 2024 Earnings Call Highlights: Strategic Advances Amid Financial Challenges [Yahoo! Finance]
11/12
04:05 pm
eyen
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
High
Report
Eyenovia Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/7
07:00 am
eyen
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th
Medium
Report
Eyenovia to Report Third Quarter 2024 Results on Tuesday, November 12th
10/23
07:00 am
eyen
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®
Low
Report
Eyenovia Announces Publication of Study Demonstrating Favorable Impact on the Ocular Surface of Medication Delivered with the Optejet®
10/16
07:00 am
eyen
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
High
Report
Eyenovia Announces Presentation of Phase 3 Clobetasol Study Results at the American Academy of Ophthalmology (AAO) 2024 Expo
10/1
07:00 am
eyen
Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device
Low
Report
Eyenovia Announces Commencement of Manufacturing of its Advanced, Second Generation Optejet Device
9/27
08:30 am
eyen
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering
High
Report
Eyenovia, Inc. Announces Pricing of $4 Million Registered Direct Offering
9/26
07:00 am
eyen
Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery
Medium
Report
Eyenovia Announces Launch and Commercial Availability of Clobetasol Propionate Ophthalmic Suspension 0.05% for Post-Operative Inflammation and Pain Following Ocular Surgery
9/9
08:01 am
eyen
Formosa Pharma ships APP13007 ophthalmic drug to US [Yahoo! Finance]
Medium
Report
Formosa Pharma ships APP13007 ophthalmic drug to US [Yahoo! Finance]
9/9
03:23 am
eyen
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization [Yahoo! Finance]
High
Report
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization [Yahoo! Finance]
9/9
03:00 am
eyen
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization
High
Report
Formosa Pharmaceuticals Makes First Shipment of APP13007 (Clobetasol Propionate Ophthalmic Suspension, 0.05%) to the United States for Commercialization
9/6
06:59 am
eyen
Eyenovia, Inc. (NASDAQ: EYEN) was upgraded by analysts at William Blair to a "strong-buy" rating.
Medium
Report
Eyenovia, Inc. (NASDAQ: EYEN) was upgraded by analysts at William Blair to a "strong-buy" rating.
9/5
07:00 am
eyen
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.
Medium
Report
Eyenovia Announces Taiwan Export License Approval to Commence Shipment of Clobetasol Propionate Ophthalmic Suspension (0.05%) to the U.S.
9/3
07:00 am
eyen
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer
Medium
Report
Eyenovia Announces Appointment of Experienced Finance and Accounting Executive Andrew Jones as Chief Financial Officer